ZA200503270B - Sustained release composition for oral administration of drugs - Google Patents

Sustained release composition for oral administration of drugs Download PDF

Info

Publication number: ZA200503270B
Authority: ZA; South Africa
Prior art keywords: drug; release; composition; drugs; carrier
Prior art date: 2002-10-23

Application number

ZA200503270A

Other languages

English (en)

Inventor

Woo Jong-Soo

Chi Moon-Hyuk

Original Assignee

Hanmi Pharm Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-23

Filing date

2005-04-22

Publication date

2006-10-25

2005-04-22 Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd

2006-10-25 Publication of ZA200503270B publication Critical patent/ZA200503270B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Neurology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200503270A 2002-10-23 2005-04-22 Sustained release composition for oral administration of drugs ZA200503270B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR1020020064940A KR100548925B1 (ko)	2002-10-23	2002-10-23	약물의 경구투여용 서방성 조성물

Publications (1)

Publication Number	Publication Date
ZA200503270B true ZA200503270B (en)	2006-10-25

Family

ID=36093911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200503270A ZA200503270B (en)	2002-10-23	2005-04-22	Sustained release composition for oral administration of drugs

Country Status (19)

Country	Link
US (1)	US7704526B2 (pt)
EP (1)	EP1413295B1 (pt)
JP (1)	JP4177227B2 (pt)
KR (1)	KR100548925B1 (pt)
CN (1)	CN100342912C (pt)
AT (1)	ATE380545T1 (pt)
AU (1)	AU2003272118B2 (pt)
BR (1)	BR0315604A (pt)
CA (1)	CA2502731C (pt)
DE (1)	DE60317993T2 (pt)
ES (1)	ES2297078T3 (pt)
IL (1)	IL167725A (pt)
MX (1)	MXPA05004018A (pt)
NZ (1)	NZ539192A (pt)
PL (1)	PL375440A1 (pt)
RU (1)	RU2295358C2 (pt)
UA (1)	UA77123C2 (pt)
WO (1)	WO2004037290A1 (pt)
ZA (1)	ZA200503270B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100598326B1 (ko) *	2004-04-10	2006-07-10	한미약품 주식회사	ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법
KR100620241B1 (ko) *	2004-10-21	2006-09-19	한국유나이티드제약 주식회사	벤라팍신 염산염의 장기지속성 경구투여 조성물
KR101366764B1 (ko)	2005-05-31	2014-02-25	주식회사 씨티씨바이오	메실산독사조신 서방정의 제조방법
CN101304764B (zh) *	2005-11-11	2012-12-05	旭化成化学株式会社	控释固体制剂
JP2009521532A (ja) *	2005-12-27	2009-06-04	モノソルアールエックスリミテッドライアビリティカンパニー	活性物質を放出するための、ｐＨ調節されたフィルム
CN101129355B (zh) *	2007-08-03	2010-12-08	山东华信制药有限公司	一种洛伐他汀缓释片及其制备方法
US20100159001A1 (en) *	2008-12-19	2010-06-24	Cardinal John R	Extended-Release Pharmaceutical Formulations
PL226261B1 (pl) *	2008-12-31	2017-07-31	Univ Jagiellonski	Kompozycja do przedłużonego uwalniania heparyny i zastosowanie żelu alginian-hydroksypropyloceluloza do przedłużonego uwalniania heparyny
WO2013023250A1 (en)	2011-08-16	2013-02-21	Baker Idi Heart & Diabetes Institute Holdings Limited	Controlled-release formulation
CN102349880B (zh) *	2011-10-12	2015-07-22	合肥华方医药科技有限公司	伊拉地平控释片及其制备方法
RU2554815C1 (ru) *	2014-06-18	2015-06-27	Общество с ограниченной ответственностью "Нанолек"	Гипотензивное средство
CN107530337B (zh)	2014-12-22	2021-07-09	贝克心脏与糖尿病研究所	治疗方法
CN107050419A (zh) *	2017-04-20	2017-08-18	上药东英（江苏）药业有限公司	一种培哚普利及其盐的渗透泵片及其制备方法
EP3501503A1 (en) *	2017-12-22	2019-06-26	Cosmo Technologies Ltd.	Solid delivery composition
CN109288808A (zh) *	2018-11-13	2019-02-01	华东理工大学	一种溶出度高的植物纤维素胶囊

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4765984A (en) *	1986-01-22	1988-08-23	Colgate-Palmolive Company	Stable single unit dose oral product
US4792452A (en)	1987-07-28	1988-12-20	E. R. Squibb & Sons, Inc.	Controlled release formulation
US5128143A (en) *	1988-09-19	1992-07-07	Edward Mendell Co., Inc.	Sustained release excipient and tablet formulation
US5415872A (en) *	1992-06-22	1995-05-16	Digestive Care Inc.	Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
AU772891B2 (en) *	1998-12-11	2004-05-13	Nostrum Pharmaceuticals, Inc.	Sustained release tablet containing hydrocolloid and cellulose ether
AU7947600A (en) *	1999-10-20	2001-04-30	Teijin Limited	Aqueous medicinal compositions
US6264981B1 (en) *	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
DK1280521T3 (da) *	2000-05-12	2005-08-08	Pharmacia & Upjohn Co Llc	Vaccinesammensætning, fremgangsmåde til fremstilling deraf og fremgangsmåde til vaccination af hvirveldyr
US6465014B1 (en) *	2001-03-21	2002-10-15	Isp Investments Inc.	pH-dependent sustained release, drug-delivery composition

2002
- 2002-10-23 KR KR1020020064940A patent/KR100548925B1/ko not_active IP Right Cessation
2003
- 2003-07-08 DE DE60317993T patent/DE60317993T2/de not_active Expired - Lifetime
- 2003-07-08 EP EP03014596A patent/EP1413295B1/en not_active Expired - Lifetime
- 2003-07-08 ES ES03014596T patent/ES2297078T3/es not_active Expired - Lifetime
- 2003-07-08 AT AT03014596T patent/ATE380545T1/de not_active IP Right Cessation
- 2003-08-27 US US10/650,931 patent/US7704526B2/en not_active Expired - Fee Related
- 2003-10-23 AU AU2003272118A patent/AU2003272118B2/en not_active Ceased
- 2003-10-23 UA UAA200504799A patent/UA77123C2/uk unknown
- 2003-10-23 CA CA002502731A patent/CA2502731C/en not_active Expired - Fee Related
- 2003-10-23 JP JP2003362832A patent/JP4177227B2/ja not_active Expired - Fee Related
- 2003-10-23 RU RU2005115483/15A patent/RU2295358C2/ru not_active IP Right Cessation
- 2003-10-23 BR BR0315604-4A patent/BR0315604A/pt not_active IP Right Cessation
- 2003-10-23 PL PL03375440A patent/PL375440A1/xx not_active IP Right Cessation
- 2003-10-23 NZ NZ539192A patent/NZ539192A/en not_active IP Right Cessation
- 2003-10-23 WO PCT/KR2003/002241 patent/WO2004037290A1/en active IP Right Grant
- 2003-10-23 MX MXPA05004018A patent/MXPA05004018A/es active IP Right Grant
- 2003-10-23 CN CNB2003801017349A patent/CN100342912C/zh not_active Expired - Fee Related
2005
- 2005-03-29 IL IL167725A patent/IL167725A/en not_active IP Right Cessation
- 2005-04-22 ZA ZA200503270A patent/ZA200503270B/en unknown

Also Published As

Publication number	Publication date
RU2295358C2 (ru)	2007-03-20
US20040081693A1 (en)	2004-04-29
CN1741819A (zh)	2006-03-01
EP1413295A1 (en)	2004-04-28
DE60317993T2 (de)	2008-04-17
CN100342912C (zh)	2007-10-17
AU2003272118A1 (en)	2004-05-13
UA77123C2 (en)	2006-10-16
US7704526B2 (en)	2010-04-27
KR100548925B1 (ko)	2006-02-02
NZ539192A (en)	2006-11-30
PL375440A1 (en)	2005-11-28
JP2004143175A (ja)	2004-05-20
DE60317993D1 (de)	2008-01-24
BR0315604A (pt)	2005-08-23
JP4177227B2 (ja)	2008-11-05
RU2005115483A (ru)	2005-11-20
MXPA05004018A (es)	2007-08-30
IL167725A (en)	2010-05-31
WO2004037290A1 (en)	2004-05-06
EP1413295B1 (en)	2007-12-12
ES2297078T3 (es)	2008-05-01
KR20040036130A (ko)	2004-04-30
CA2502731C (en)	2009-03-17
AU2003272118B2 (en)	2007-03-08
ATE380545T1 (de)	2007-12-15
CA2502731A1 (en)	2004-05-06

Publication	Publication Date	Title
ZA200503270B (en)	2006-10-25	Sustained release composition for oral administration of drugs
EP1008354B1 (en)	2008-06-04	Immediately disintegrable medicinal compositions
US5593696A (en)	1997-01-14	Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US20070042042A1 (en)	2007-02-22	Metformin Tablet with Sustained Release and Method for Preparing the Same
WO2010128525A2 (en)	2010-11-11	A formulation of ivabradine for treating the cardiovascular disease
RU2005141293A (ru)	2007-07-10	Двуслойные таблетки окскарбазепина для регулируемой доставки и способ их получения
US20100285125A1 (en)	2010-11-11	Delivery system for poorly soluble drugs
CN101711747A (zh)	2010-05-26	一种治疗高血压的药物应用制剂
CN1938007A (zh)	2007-03-28	用于口服二甲双胍的控释配方
RU2616263C2 (ru)	2017-04-13	Таблетка с замедленным высвобождением, содержащая леводропропизин, и способ ее изготовления
US7759368B2 (en)	2010-07-20	Sustained release composition for oral administration of niacin
CN101390844A (zh)	2009-03-25	精氨酸布洛芬片剂及其制备方法
KR101175816B1 (ko)	2012-08-24	경구 서방성 정제
KR102376010B1 (ko)	2022-03-18	아스피린 및 티카그렐러를 포함하는 유핵정 복합제제
KR102786876B1 (ko)	2025-03-26	티카그렐러 또는 이의 약학적으로 허용 가능한 염을 유효 성분으로 포함하는 서방성 다층정제 및 이의 제조 방법
CA2343270C (en)	2006-11-07	Methazolamide compositions and method of use
CN100508977C (zh)	2009-07-08	美托法宗缓释片
EP2676661A2 (en)	2013-12-25	Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
EP3153157A1 (en)	2017-04-12	Pharmaceutical composition for prolonged release of nevirapine
WO2008038106A1 (en)	2008-04-03	Venlafaxine extended release formulations
KR20190115948A (ko)	2019-10-14	다파글리플로진 l-프롤린을 포함하는 당뇨병 질환의 예방 또는 치료용 약제학적 조성물